What Australian women want and when they want it: Cervical screening testing preferences, decision-making styles and information needs

Health Expectations

Volumn 16, Issue 2, 2013, Pages 177-188

  Dieng, Mbathio ^a   Trevena, Lyndal ^a   Turner, Robin M ^a   Wadolowski, Monika ^b   Mccaffery, Kirsten ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Abnormal pap smear results; Australia; Cervical cancer screening; Decision making; Information needs

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; DECISION MAKING; EARLY DIAGNOSIS; FEMALE; HEALTH SERVICE; HUMAN; INFORMATION SEEKING; MIDDLE AGED; PAPANICOLAOU TEST; PATIENT PREFERENCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STATISTICS; UTERINE CERVIX TUMOR; YOUNG ADULT; EPIDEMIOLOGY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; AUSTRALIA; DECISION MAKING; EARLY DETECTION OF CANCER; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INFORMATION SEEKING BEHAVIOR; MIDDLE AGED; PAPANICOLAOU TEST; PATIENT PREFERENCE; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84877637898     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/j.1369-7625.2011.00707.x     Document Type: Article

References (34)

1. Dillner J, Rebolj M, Birembaut P et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ, 2008; 337: a1754.
2. Cuzick J, Szarewski A, Mesher D et al. Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology Results from the Hammersmith study. International Journal of Cancer, 2008; 122: 2294-2300.
3. Mayrand MH, Duarte-Franco E, Rodrigues I et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. New England Journal of Medicine, 2007; 357: 1579-1588.
4. ASCUS LSIL Triage Study (ALTS) Group. A randomized trial on the management of LSIL cytology interpretations. American Journal of Obstetrics and Gynecology, 2003; 188: 1393-1400.
5. National Health and Medical Research Council Cervical Screening Guidelines Review Group. Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities. 2005 Available at: http://www.nhmrc.gov.au/publications, accessed 25 March 2010.
6. NHS Cervical Screening Programme: Colposcopy and Programme Management. Publication 20. 2004. Available at: http://www.bsccp.org.uk/docs/public/pdf/nhscsp20.pdf
7. American College of Obstetricians and Gynaecologists. Cervical cytology screening. ACOG Practice Bulletin number 109. Obstetrics and Gynecology, 2009; 114: 1409-1420.
8. Schwartz LM, Woloshin S, Floyd J et al. Enthusiasm for cancer screening in the United States. JAMA, 2004; 291: 71-78.
9. Sirovich BE, Woloshin S, Schwartz L. Screening for cervical cancer: will women accept less?American Journal of Medicine, 2005; 118: 151-158.
10. Fiebig DG, Haas M, Hossain I et al. Decision about Pap tests: what influences women and providers?Social Science and Medicine, 2009; 68: 1766-1774.
11. McCaffery K, Irwig L, Turner R et al. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial. BMJ, 2010; 340: b4491.
12. Entwistle VA, Carter SM, Trevena L et al. Communicating about screening. BMJ, 2008; 337: a1591.
13. Sirovich BE, Welch HG. The Frequency of Pap smears Screening in the United States. Journal of General Internal Medicine, 2004; 19: 243-250.
14. Davey HM, Lim J, Butow PN et al. Consumer information materials for diagnostic breast tests: women's views on information and their understanding of test results. Health Expectations, 2003; 6: 298-311.
15. Smith M, French L, Barry HC. Periodic Abstinence From Pap (PAP) Smear Study: women's Perceptions of Pap smear Screening. Annals of Family Medicine, 2003; 1: 203-208.
16. Rolnick SJ, LaFerla JJ, Jackson J et al. Impact of a new cervical Pap smear screening guideline on perceptions and comfort levels. Preventive Medicine, 1999; 28: 530-534.
17. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. The Canadian Journal of Nursing Research, 1997; 29: 21-43.
18. SAS Institute Inc. SAS System Version 9. SAS Institute Inc, Cary, NC, USA, 20022003.
19. Australian Bureau of Statistics. Available at http://www.abs.gov.au/, accessed 2 July 2010.
20. Australian Institute of Health and Welfare. Cervical Screening in Australia 2004-2005. Cancer Series no. 38. Cat. No. CAN 33. Canberra: AIHW, 2007.
21. Sawaya GF, McConnell KJ, Kulasingam SL et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. New England Journal of Medicine, 2003; 349: 1501-1509.
22. Ronco G, Giorgi-Rossi P, Carozzi F et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. The Lancet Oncology, 2010; 11: 249-257.
23. Smith SK, Trevena L, Simpson J et al. A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ, 2010; 341: c5370.
24. General Medical Council. Consent: Patients and Doctors Making Decisions Together. London: GMC, 2008.
25. Pitts M, Clarke T. Human papillomavirus and risks of cervical cancer: what do women know?. Health Education research, 2002; 6: 706-714.
26. Whynes DK, Clarke K, Philips Z et al. Cervical cancer screening and perceived information needs. Health Education, 2005; 105: 289-303.
27. Greimel ER, Gappmayer-Locker E, Girardi FL et al. Increasing women's knowledge and satisfaction with cervical cancer screening. Journal of Psychosomatic Obstetrics and Gynaecology, 1997; 18: 273-279.
28. Bessel TL, Anderson JN, Hiller JE et al. Prevalence of South Australia's online health seekers. Australian and New Zealand Journal of Public Health, 2002; 26: 170-173.
29. Gray NM, Sharp L, Cotton SC et al. Psychological effects of low-grade abnormal cervical smear test result: anxiety and associated factors. British Journal of Cancer, 2006; 94: 1253-1262.
30. McCaffery K, Waller J, Forrest S et al. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG, 2004; 111: 1437-1443.
31. French DP, Maissi E, Marteau TM. Psychological costs of inadequate cervical smear test results. British Journal of Cancer, 2004; 91: 1887-1892.
32. Maissi E, Marteau TM, Hankins M et al. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. BMJ, 2004; 328: 1293.
33. Rogstad KE. The psychological impact of abnormal cytology and colposcopy. BJOG, 2002; 109: 364-368.
34. Goldsmith MR, Austoker J, Marsh G et al. Cervical screening result communication: a focus-group investigation of English women's experiences and needs. Quality and Safe in Health Care, 2008; 17: 334-338.